Discover the latest news and updates from Immundiagnostik, Inc.
In this blog series, we aim to apply the cardiac biomarker continuum framework to cardiovascular research design across three biological stages: vascular inflammation and oxidative stress, myocardial injury, and cardiac stress and dysfunction.
This article focuses on three complementary biomarkers to study vascular inflammation and oxidative stress: asymmetric dimethylarginine (ADMA), oxidized LDL (oxLDL), and myeloperoxidase (MPO).
In this article, we discuss how investigating high-sensitivity troponins can enhance our understanding of myocardial injury, asymptomatic progression, and its implications for cardiovascular health.
In this article, we explore the importance of utilizing NT-proBNP within the cardiac biomarker continuum to investigate cardiac stress, remodeling, and the progression toward heart failure.
Discover how measuring DKK3 in urine can help investigate chronic kidney disease progression.
Read our blog post to discover more about the relationship between secretory IgA and intestinal mucosal barrier function.
Meet the ECL100, a fully automated chemiluminescent immunoassay analyzer designed to transform lab efficiency.
Immundiagnostik, Inc. will showcase the ECL100 Chemiluminescent Immunoassay Analyzer and QSE180 Autosampler at Booth 2240 during the 2025 ADLM Clinical Lab Expo in Chicago July 29–31.
